Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tytonis is a privately owned life sciences consulting and advisory firm founded in 2006 by Dr. Henrik Luessen. The company specializes in providing strategic advisory, interim management, and business development support to pharmaceutical and biotechnology companies. It operates through an international network of partners with offices in the Netherlands (HQ), Switzerland, Germany, France, USA (Washington DC and Boston), and Korea (Seoul). Services are offered flexibly on a fee-for-service or project basis[2][3][4][7].
Note: Tytonis does not develop drugs or have its own R&D pipeline but acts as an advisor/interim manager/business developer within life science sectors globally through its independent network structure.[2][3][4][7]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tytonis.